New pill tested to knock out common RSV virus
Disease control
Completed
This study tested if a new oral medication called EDP-323 could safely reduce Respiratory Syncytial Virus (RSV) in healthy adults. Researchers intentionally exposed 142 healthy volunteers to RSV and gave them either the drug or a placebo pill. The main goal was to see if the drug…
Phase: PHASE2 • Sponsor: Enanta Pharmaceuticals, Inc • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC